Literature DB >> 1880541

Total ion content of skeletal and cardiac muscle in the mdx mouse dystrophy: Ca2+ is elevated at all ages.

J F Dunn1, G K Radda.   

Abstract

The mdx mouse has been shown to have a gene defect at the locus which is homologous to that which is defective in Duchenne muscular dystrophy and they both lack dystrophin, the protein product of this defective gene. The exact cause of myofibre necrosis in DMD is not known but there is evidence to support a causal relationship between elevated calcium and tissue necrosis. Since the mdx mouse exhibits age-dependent changes in the proportion of tissue necrosis, we have measured total ion content (Ca2+, Na+, K+, and Mg2+) in the heart and skeletal muscle of animals at different ages to determine if ionic changes correlate with reported periods of necrosis. Total calcium is elevated throughout the ages studied (10 days, 30 days and 254-347 days) in both tissues and does not correlate with necrosis, although it appears that pre-necrotic tissues do not exhibit such a wide variation in calcium content as is observed in tissues from older animals. These changes are discussed with reference to the other ions measured and to the regulation of intracellular calcium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1880541     DOI: 10.1016/0022-510x(91)90168-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

2.  Muscular dystrophy: from gene to patient.

Authors:  J C Hopkins; B L Bia; J G Crilley; E A Boehm; A E Sang; J M Tinsley; L M King; G K Radda; K E Davies; K Clarke
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.310

3.  Comparative study of calcium and calcium-related enzymes with differentiation markers in different ages and muscle types in mdx mice.

Authors:  Rhayanna B Gaglianone; Flavia Fonseca Bloise; Tania Maria Ortiga-Carvalho; Thereza Quirico-Santos; Manoel Luis Costa; Claudia Mermelstein
Journal:  Histol Histopathol       Date:  2019-07-05       Impact factor: 2.303

4.  Intracellular Ca2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres.

Authors:  J Pressmar; H Brinkmeier; M J Seewald; T Naumann; R Rüdel
Journal:  Pflugers Arch       Date:  1994-04       Impact factor: 3.657

5.  Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency.

Authors:  M Khairallah; R J Khairallah; M E Young; B G Allen; M A Gillis; G Danialou; C F Deschepper; B J Petrof; C Des Rosiers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

6.  Heterokaryon myotubes with normal mouse and Duchenne nuclei exhibit sarcolemmal dystrophin staining and efficient intracellular free calcium control.

Authors:  W F Denetclaw; G Bi; D V Pham; R A Steinhardt
Journal:  Mol Biol Cell       Date:  1993-09       Impact factor: 4.138

7.  Modulation by prednisolone of calcium handling in skeletal muscle cells.

Authors:  L Metzinger; A C Passaquin; W J Leijendekker; P Poindron; U T Rüegg
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

8.  SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals.

Authors:  Sophie Bouyon; Véronique Roussel; Yves Fromes
Journal:  Hum Gene Ther       Date:  2014-08       Impact factor: 5.695

9.  Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation.

Authors:  W F Denetclaw; F W Hopf; G A Cox; J S Chamberlain; R A Steinhardt
Journal:  Mol Biol Cell       Date:  1994-10       Impact factor: 4.138

10.  SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice.

Authors:  Jin-Hong Shin; Brian Bostick; Yongping Yue; Roger Hajjar; Dongsheng Duan
Journal:  J Transl Med       Date:  2011-08-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.